House Panel Questions Ties Between Not-for-Profit Company Hired To Design New Drug Ad Web Site, Drug Marketing Firm

Main Category: IT / Internet / E-mail
Also Included In: Pharma Industry / Biotech Industry
Article Date: 16 Oct 2008 - 7:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  

Current Article Ratings:

Patient / Public:not yet rated

Healthcare Prof:not yet rated


House Energy and Commerce Committee Chair John Dingell (D-Mich.) and Oversight and Investigations Subcommittee Chair Bart Stupak (D-Mich.) on Tuesday sent a letter to FDA inquiring about the agency's decision to employ a not-for-profit group with ties to a drug marketing firm to design a new agency Web site that aims to help consumers understand drug advertisements, CQ Today reports. The new Web site, "Be Smart About Prescription Drugs: A Guide For Consumers," was created by EthicAd, a not-for-profit organization funded by the drug marketing firm Shaw Science Partners, according to Dingell and Stupak. Shaw's clients include AstraZeneca, Merck, Pfizer, Eli Lilly, Bayer and Wyeth. According to EthicAd's Web site, EthicAd in November 2000 agreed to create FDA's drug ad information Web site. The information was compiled by EthicAd volunteers on a pro bono basis, and the FDA Web site was launched in September 2008.

EthicAd and Shaw are located in different suites in the same Georgia building but EthicAd lists no contact information on its Web site. Shaw President Michael Shaw serves as EthicAd's executive director, according to his 2001 testimony before the Senate Commerce, Science and Transportation Committee.

In the letter, Dingell and Stupak asked "why FDA sought the assistance of a pharmaceutical public relations firm to help it advise consumers on how to interpret ... advertisements." Dingell in a statement said he "had serious concerns that the leading pharmaceutical companies do not share our commitment to providing consumers with accurate information about drug therapies." Dingell and Stupak sent similar letters to Michael Shaw at EthicAd and at Shaw Science Partners. Michael Shaw could not be reached for comment on Tuesday (Armstrong, CQ Today, 10/14).

Reprinted with kind permission from http://www.kaisernetwork.org. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation.

© 2008 Advisory Board Company and Kaiser Family Foundation. All rights reserved.

Article adapted by Medical News Today from original press release.
Visit our it / internet / e-mail section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
Kaiser. "House Panel Questions Ties Between Not-for-Profit Company Hired To Design New Drug Ad Web Site, Drug Marketing Firm." Medical News Today. MediLexicon, Intl., 16 Oct. 2008. Web.
14 Feb. 2012. <http://www.medicalnewstoday.com/releases/125675.php>

APA
Kaiser. (2008, October 16). "House Panel Questions Ties Between Not-for-Profit Company Hired To Design New Drug Ad Web Site, Drug Marketing Firm." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/125675.php.

Please note: If no author information is provided, the source is cited instead.


IT / Internet / E-mail

Most Popular Articles



Follow Our IT News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our IT / Internet / E-mail Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »